07:06 AM EST, 02/28/2025 (MT Newswires) -- ANI Pharmaceuticals ( ANIP ) reported Q4 adjusted earnings Friday of $1.63 per diluted share, up from $1 a year earlier.

Analysts polled by FactSet expected $1.44.

Revenue for the quarter ended Dec. 31 was $190.6 million compared with $131.7 million a year earlier.

Analysts surveyed by FactSet expected $175.4 million.

The company said it expects 2025 adjusted earnings of $6.12 to $6.49 per diluted share. Analysts surveyed by FactSet expect $5.56.

The company raised its revenue for the year to a range of $756 million to $776 million from a range of $739 million to $759 million. Analysts polled by FactSet expect $724.9 million.